Dr. Alan L. Epstein, M.D.
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 47
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 596
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
PA license MD033529E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Thomas Jefferson University Hospital Philadelphia, PA
- Penn Presbyterian Medical Center Philadelphia, PA
- Pennsylvania Hospital Philadelphia, PA
- Jefferson Einstein Philadelphia Hospital Philadelphia, PA
Medical groups
- University of Penn - Medical Group (3,505 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 596
- Services billed
- 111,899
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, golimumab, 1 mg, for intravenous use | 19,126 | 23 |
| Injection, romosozumab-aqqg, 1 mg | 14,700 | 14 |
| Injection, denosumab, 1 mg | 9,780 | 95 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,118 | 437 |
| Insertion of needle into vein for collection of blood sample | 449 | 239 |
| Injection of drug or substance under skin or into muscle | 315 | 104 |
| Administration of chemotherapy into vein, 1 hour or less | 195 | 35 |
| Injection, zoledronic acid, 1 mg | 110 | 22 |
| Injection, methylprednisolone acetate, 40 mg | 104 | 67 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 79 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 68 payments worth $48,294 in total to this clinician.
| Janssen Biotech, Inc. | $16,096 |
|---|---|
| GlaxoSmithKline, LLC. | $11,050 |
| AbbVie Inc. | $7,478 |
| AstraZeneca Pharmaceuticals LP | $3,813 |
| Sobi, Inc | $2,810 |
| Janssen Scientific Affairs, LLC | $2,565 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,073 |
| Invivyd Inc | $2,013 |
| Compensation for services other than consulting (speaking, faculty) | $32,493 |
|---|---|
| Consulting Fee | $11,952 |
| Travel and Lodging | $2,216 |
| Food and Beverage | $1,578 |
| Education | $54.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) BENLYSTA · IMMUNOLOGY | $5,200 |
| GlaxoSmithKline, LLC. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) BENLYSTA · IMMUNOLOGY | $5,200 |
| Janssen Biotech, Inc. Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $4,655 |
| Janssen Biotech, Inc. May 3, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $3,263 |
| AbbVie Inc. Mar 14, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $2,750 |
| Sobi, Inc Oct 7, 2025 | Consulting Fee | $2,664 |
| Janssen Scientific Affairs, LLC May 10, 2025 | Consulting Fee TREMFYA · Immunology | $2,565 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) SAPHNELO · Inflammation and Autoimmunity Company’s descriptionSpeaker Fee | $2,500 |
| Janssen Biotech, Inc. Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $2,175 |
| Invivyd Inc Mar 27, 2025 | Consulting Fee PEMGARDA · INFECTIOUS DISEASE | $2,013 |
All 27 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Oct 27, 2025 | Education TREMFYA · Immunology · in-kind | $54.99 |
| Sobi, Inc Oct 7, 2025 | Consulting Fee | $2,664 |
| GlaxoSmithKline, LLC. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) BENLYSTA · IMMUNOLOGY | $650 |
| Janssen Biotech, Inc. Aug 2, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $1,269 |
| AbbVie Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,500 |
| Janssen Biotech, Inc. Jun 21, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA · Immunology | $906 |
| GlaxoSmithKline, LLC. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) BENLYSTA · IMMUNOLOGY | $5,200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 30, 2025 | Consulting Fee | $1,960 |
| Janssen Scientific Affairs, LLC May 10, 2025 | Consulting Fee TREMFYA · Immunology | $2,565 |
| Janssen Biotech, Inc. May 3, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $3,263 |
| Janssen Biotech, Inc. Apr 19, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $1,450 |
| Janssen Biotech, Inc. Apr 19, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $725 |
| Janssen Biotech, Inc. Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $2,175 |
| Invivyd Inc Mar 27, 2025 | Consulting Fee PEMGARDA · INFECTIOUS DISEASE | $2,013 |
| Janssen Biotech, Inc. Mar 21, 2025 | Compensation for services other than consulting (speaking, faculty) TREMFYA; SIMPONI ARIA · Immunology | $4,655 |
| Janssen Biotech, Inc. Mar 17, 2025 | Travel and Lodging TREMFYA; SIMPONI ARIA · Immunology · travel to CHANDLER, AZ | $114 |
| AbbVie Inc. Mar 14, 2025 | Consulting Fee SKYRIZI · IMMUNOLOGY | $2,750 |
| AbbVie Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,500 |
| AbbVie Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,500 |
| Janssen Biotech, Inc. Mar 8, 2025 | Travel and Lodging TREMFYA; SIMPONI ARIA · Immunology · travel to CHANDLER, AZ · in-kind | $592 |
| Janssen Biotech, Inc. Mar 8, 2025 | Travel and Lodging TREMFYA; SIMPONI ARIA · Immunology · travel to CHANDLER, AZ · in-kind | $424 |
| Janssen Biotech, Inc. Mar 8, 2025 | Travel and Lodging TREMFYA; SIMPONI ARIA · Immunology · travel to CHANDLER, AZ · in-kind | $327 |
| AstraZeneca Pharmaceuticals LP Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) SAPHNELO · Inflammation and Autoimmunity Company’s descriptionSpeaker Fee | $2,500 |
| AstraZeneca Pharmaceuticals LP Feb 1, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Denver, CO · in-kind Company’s descriptionSpeaker Expenses | $155 |
| AstraZeneca Pharmaceuticals LP Jan 31, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Denver, CO · in-kind Company’s descriptionSpeaker Expenses | $339 |
| AstraZeneca Pharmaceuticals LP Jan 31, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Denver, CO · in-kind Company’s descriptionSpeaker Expenses | $266 |
| GlaxoSmithKline, LLC. Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) BENLYSTA · IMMUNOLOGY | $5,200 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.